Spain, March 12 -- Spain based ASTRAZENECA FARMACAUTICA SPAIN, S.A. has secured contract from HOSPITAL CLINICO SAN CARLOS DE MADRID for Pharmaceutical products Supply of tremelimumab imjudo and tezepelumab tezspire exclusively distributed by the Astrazeneca pharmaceutical Spain SA laboratory for the Pharmacy Service of the San Carlos Clinical Hospital in Madrid. The value of the contract is worth 7636356 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....